SCHEMBL5586772

SCHEMBL5586772

COc1c(O)c(C(=O)O)c(F)c(F)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.45
MEN1 O00255 8/20 0.45
CYP2C9 P11712 2/20 0.45
CYP1A2 P05177 1/20 0.45
TSHR P16473 2/20 0.44
GFER P55789 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 1/20 0.36
POLB P06746 2/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378544 0.85 KMT2A (0.49) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL29710578 0.85 KMT2A (0.49) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL4247568 0.83 KMT2A (0.51) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL5702932 0.83 MEN1 (0.54) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL5590173 0.82 MEN1 (0.33) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL8464230 0.81 KMT2A (0.53) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL29154296 0.81 MEN1 (0.53) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL5587536 0.79 ESR1 (0.37) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL27666768 0.78 KMT2A (0.44) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL25368089 0.78 MEN1 (0.54) KMT2AMEN1CYP2C9CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 KMT2A 1733/4885MEN1 3377/4885CYP2C9 3617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.